Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
7.68
-0.44 (-5.42%)
Nov 18, 2024, 12:55 PM EST - Market open
Camp4 Therapeutics Employees
Camp4 Therapeutics had 64 employees as of December 31, 2023.
Employees
64
Change
n/a
Growth
n/a
Revenue / Employee
$5,469
Profits / Employee
-$776,766
Market Cap
149.80M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 64 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Holdings | 984 |
| Nutex Health | 800 |
| Tenaya Therapeutics | 140 |
| Senseonics Holdings | 132 |
| Alpha Tau Medical | 121 |
| Fulcrum Therapeutics | 76 |
| Lineage Cell Therapeutics | 75 |
| Atossa Therapeutics | 12 |
CAMP News
- 2 months ago - Genetic disease biotech CAMP4 Therapeutics files for a $75 million IPO - Renaissance Capital
- 2 months ago - Kaiser Permanente-backed biopharma CAMP4 files for US IPO - Reuters
- 2 months ago - CAMP4 Therapeutics IPO Registration Document (S-1) - SEC
- 2 months ago - CAMP4 Therapeutics Secures Orphan Drug Designation for CMP-CPS-001 for the Treatment of Urea Cycle Disorders - GLOBE NEWSWIRE